Mohmmed Tauseef Sharip

9PUBLICATIONS
41CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Medical mycologyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 11, 2026
Mirikizumab is equally effective in ustekinumab-exposed and ustekinumab-naïve patients with UC: a multicenter real-world cohort.

|Jun 10, 2026
Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease.

|May 22, 2026
Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial.

|Dec 13, 2025
HLA-DQA1*05:01 and DQA1*05:05 inform choice of anti-tumor necrosis factor and concomitant use of immunomodulators in patients with inflammatory bowel disease.

Qian Zhang, Mohammed Sharip, Christopher Roberts

|Jun 23, 2025
Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource.

Christopher Roberts, Jaime Peters, Aleksejs Sazonvos

|Jul 16, 2024
Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?

Mohmmed Tauseef Sharip, Miles Parkes, Sreedhar Subramanian

Pageof 2

Frequent Collaborators

3 joint publications

Tariq Ahmad

2 joint publications

Christopher Roberts

2 joint publications

Miles Parkes

2 joint publications

Nurulamin M Noor